Long-term effects of weight-reducing drugs in people with hypertension-Reference-Cited by-同舟云学术

Long-term effects of weight-reducing drugs in people with hypertension

Published:2016-03-02 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Siebenhofer Andrea¹,Jeitler Klaus²,Horvath Karl³,Berghold Andrea²,Posch Nicole⁴,Meschik Jutta⁴,Semlitsch Thomas⁴

Affiliation:

1. Graz, Austria / Institute of General Practice, Goethe University; Institute of General Practice and Evidence-Based Health Services Research, Medical University of Graz; Frankfurt am Main Germany

2. Medical University of Graz; Institute of General Practice and Evidence-Based Health Services Research / Institute of Medical Informatics, Statistics and Documentation; Auenbruggerplatz 2/9 Graz Austria 8036

3. Medical University of Graz; Institute of General Practice and Evidence-Based Health Services Research / Department of Internal Medicine, Division of Endocrinology and Metabolism; Auenbruggerplatz 2/9 Graz Austria 8036

4. Medical University of Graz; Institute of General Practice and Evidence-Based Health Services Research; Auenbruggerplatz 2/9 Graz Austria 8036

Publisher

Wiley

Subject

Pharmacology (medical)

Reference196 articles.

1. Orlistat improves blood pressure control in obese subjects with treated but inadequately controlled hypertension;Bakris;Journal of Hypertension,2002

2. Sufficient weight reduction decreases cardiovascular complications in diabetic patients with the metabolic syndrome: A randomized study of orlistat as an adjunct to lifestyle changes (diet and exercise);Cocco;Heart Drug,2005

3. Weight loss and improvements in cardiometabolic outcomes with extended-release phentermine/topiramate treatment in overweight/obese subjects with type 2 diabetes;Astrup;Diabetologia,2012

4. Reduction of cardiovascular risk factors by magnitude of weight loss in obese and overweight subjects with >2 comorbidities;Cheskin;Journal of General Internal Medicine,2013

5. Improved cardiometabolic risk factors in overweight/obese subjects receiving controlled-release phentermine/topiramate (PHEN/TPM CR);Cheskin;Diabetes,2012

Cited by 77 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Freeze-dried biotics based on Lactiplantibacillus plantarum and Lactiplantibacillus paraplantarum with enhanced selected biological activity;LWT;2024-07

2. Current options in obesity pharmacotherapy for children and adolescents;Precision and Future Medicine;2024-06-30

3. Assessment and Management of Patients with Obesity and Hypertension in European Society of Hypertension Excellence Centres. A survey from the ESH Working Group on Diabetes and Metabolic Risk Factors.;Blood Pressure;2024-02-26

4. Large area fractional laser treatment of mouse skin increases energy expenditure;iScience;2024-01

5. Identification of pancreatic lipase inhibitors from Eucommia ulmoides tea by affinity-ultrafiltration combined UPLC-Orbitrap MS and in vitro validation;Food Chemistry;2023-11